A Phase 0, Multi-dose, Open-label, Clinical Trial To Investigate The Safety of a Micro-dose of a Nanocelle (Trademark) Atorvastatin Formulation Administered Oro-buccally in Healthy Adult Volunteers

Trial Profile

A Phase 0, Multi-dose, Open-label, Clinical Trial To Investigate The Safety of a Micro-dose of a Nanocelle (Trademark) Atorvastatin Formulation Administered Oro-buccally in Healthy Adult Volunteers

Not yet recruiting
Phase of Trial: Phase 0

Latest Information Update: 10 Aug 2016

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Adverse reactions
  • Sponsors Medlab
  • Most Recent Events

    • 03 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top